Ludwig-Maximilians-Universität München
print

Language Selection

Breadcrumb Navigation


Content

Munich Cluster for Systems Neurology (SyNergy)

Neurodegenerative, inflammatory and vascular disorders have traditionally been studied in isolation from each other. The Munich Cluster for Systems Neurology (SyNergy) has chosen to take an integrative approach with a view to breaking down such artificial boundaries and unravel the interactions between the different underlying pathologies that contribute to the development of neurological disease. Thus, the researchers involved in the Cluster study how inflammation reactions influence neurodegenerative processes, how microvascular and degenerative mechanisms combine to cause tissue damage, and how immune cells interact with the blood-brain barrier. To tackle these issues, the SyNergy Cluster, which was established in the second phase of the Excellence Initiative, has created a network of highly qualified specialists, which brings basic and clinical researchers together with experts in systems analysis.

Within the Excellence Strategy, SyNergy has secured funding for another seven years from 01.01.2019. The successful proposal was put forward jointly by LMU and the Technical University of Munich (TUM).

 

Cooperation partners:
Technical University of Munich, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Helmholtz Center Munich – National Research Center for Environmental Health, Max Planck Institutes for Biochemistry, Neurobiology and Psychatrie

Funded: 1 Nov 2012 through 31 Dec 2018

Coordinator:
Prof. Dr. Christian Haass
Chair of Metabolic Biochemistry
Adolf Butenandt Institute - Faculty of Medicine
Phone: +49 (0) 89 / 2180 75 – 471
Fax: +49 (0) 89 / 2180 75 – 415
E-Mail: chaass@med.uni-muenchen.de
Web: www.biochemie.abi.med.uni-muenchen.de/haass1/index.html

Website: http://www.synergy-munich.de